Alteogen, Inc.
Alteogen is a biopharmaceutical company dedicated to developing innovative antibody therapeutics. Their mission is to create effective treatments for patients worldwide, focusing on antibody engineering and biosimilar development.
Industries
Nr. of Employees
medium (51-250)
Patents
Products
NexP™ Fusion Technology
A technology that uses human A1AT protein as a carrier to increase the half-life of biomedicines.
NexMab™ ADC Technology
A proprietary Antibody-Drug Conjugate technology designed for stability and efficacy in drug delivery.
Hybrozyme™ Technology
A human hyaluronidase PH20 variant that converts intravenous drugs to subcutaneous delivery with improved thermal stability.
Biosimilars
Biologic drugs that are highly similar to approved biologics, developed using proprietary technology.
ALT-B4
A recombinant human hyaluronidase enzyme that enables large volume subcutaneous administration of drugs typically given via IV infusion.
NexP™ Fusion Technology
A technology that uses human A1AT protein as a carrier to increase the half-life of biomedicines.
NexMab™ ADC Technology
A proprietary Antibody-Drug Conjugate technology designed for stability and efficacy in drug delivery.
Hybrozyme™ Technology
A human hyaluronidase PH20 variant that converts intravenous drugs to subcutaneous delivery with improved thermal stability.
Biosimilars
Biologic drugs that are highly similar to approved biologics, developed using proprietary technology.
ALT-B4
A recombinant human hyaluronidase enzyme that enables large volume subcutaneous administration of drugs typically given via IV infusion.